Squamous cell carcinoma of oral cavity and lip

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:502369
Who is this for?
Show terms as
18Active trials64Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Squamous cell carcinoma of the oral cavity and lip (also called oral squamous cell carcinoma, or OSCC) is a type of cancer that starts in the flat, thin cells lining the inside of the mouth, lips, tongue, gums, cheeks, floor of the mouth, and the roof of the mouth. It is the most common type of mouth cancer. The cancer begins when these cells grow out of control and form a tumor. If not caught early, it can spread to nearby lymph nodes in the neck and, in more advanced cases, to other parts of the body. The most common warning signs include a sore in the mouth that does not heal, a white or red patch on the gums or tongue, pain or difficulty swallowing, a lump in the neck, and unexplained bleeding in the mouth. Risk factors include tobacco use (smoking or chewing), heavy alcohol use, infection with certain strains of human papillomavirus (HPV), and prolonged sun exposure to the lips. Treatment depends on how advanced the cancer is. Options include surgery to remove the tumor, radiation therapy, chemotherapy, and targeted drug therapy. Immunotherapy drugs such as pembrolizumab (Keytruda) and nivolumab (Opdivo) are FDA-approved for certain cases of head and neck squamous cell carcinoma. When found early, this cancer is often very treatable. Regular dental check-ups play an important role in early detection.

Key symptoms:

A sore or ulcer in the mouth that does not heal after two to three weeksA white patch (leukoplakia) or red patch (erythroplakia) inside the mouthPain or difficulty swallowing or chewingA lump or thickening in the cheek, tongue, or lipUnexplained bleeding in the mouthNumbness or loss of feeling in the tongue or other areas of the mouthLoose teeth with no dental causeA persistent sore throat or hoarse voiceA lump or swelling in the neckJaw pain or stiffnessUnexplained weight lossChanges in how dentures fitEar pain on one side without hearing loss

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jan 2027Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology — PHASE3

TrialNOT YET RECRUITING
Oct 2026Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING
Jan 2026Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study

Vanessa Torrecillas — NA

TrialRECRUITING
Jul 2025Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

University of Michigan Rogel Cancer Center — PHASE2

TrialRECRUITING
May 2025Microbiome in Head and Neck Squamous Cell Carcinoma

University of Colorado, Denver

TrialRECRUITING
Apr 2024A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

University of Texas Southwestern Medical Center — PHASE2

TrialRECRUITING
Feb 2024GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

GeneMedicine Co., Ltd. — PHASE1, PHASE2

TrialRECRUITING
Aug 2023The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

Medical University of South Carolina — NA

TrialRECRUITING
Jul 2023Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy

University of Wisconsin, Madison — PHASE1

TrialACTIVE NOT RECRUITING
Jun 2023Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

ECOG-ACRIN Cancer Research Group — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Squamous cell carcinoma of oral cavity and lip.

18 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

18 recruitingView all trials with filters →
Phase 32 trials
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase 3
Active
PI: Mitchell Machtay, MD (Milton S. Hershey Medical Center, Penn State Healt) · Sites: Birmingham, Alabama; Tucson, Arizona +262 more · Age: 1899 yrs
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 3
Active
PI: David J Sher (ECOG-ACRIN Cancer Research Group) · Sites: Tampa, Florida; Tampa, Florida +49 more · Age: 1899 yrs
Phase 25 trials
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2
Actively Recruiting
PI: Nabil F Saba (NRG Oncology) · Sites: Sacramento, California; Council Bluffs, Iowa +17 more · Age: 1899 yrs
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
Phase 2
Active
PI: Jacob S Thomas (City of Hope Comprehensive Cancer Center LAO) · Sites: Duarte, California; Irvine, California +18 more · Age: 1899 yrs
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma
Phase 2
Active
PI: Jared Weiss, MD (University of North Carolina, Chapel Hill) · Sites: Chapel Hill, North Carolina; Nashville, Tennessee · Age: 1899 yrs
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
Phase 2
Actively Recruiting
· Sites: Dallas, Texas · Age: 1899 yrs
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Phase 2
Actively Recruiting
PI: Jennifer L Shah (University of Michigan Rogel Cancer Center) · Sites: Ann Arbor, Michigan · Age: 1899 yrs
Phase 13 trials
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Phase 1
Active
PI: Maura L Gillison (NRG Oncology) · Sites: Gilbert, Arizona; Phoenix, Arizona +25 more · Age: 1899 yrs
Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
Phase 1
Active
PI: Randall Kimple, MD, PhD (University of Wisconsin, Madison) · Sites: Madison, Wisconsin · Age: 1890 yrs
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
Phase 1
Active
PI: Brenden Curti, MD (Providence Health & Services) · Sites: Portland, Oregon · Age: 1899 yrs
N/A4 trials
Deciphering Mechanisms Underlying Cancer Immunogenicity
N/A
Actively Recruiting
· Sites: Toulouse; Toulouse +1 more · Age: 1899 yrs
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
N/A
Actively Recruiting
PI: Vanessa Torrecillas, MD (University of Virginia) · Sites: Charlottesville, Virginia · Age: 1899 yrs
Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation
N/A
Actively Recruiting
PI: David T. Kent, MD (Vanderbilt University Medical Center) · Sites: Nashville, Tennessee · Age: 1899 yrs
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
N/A
Actively Recruiting
PI: Katherine R Sterba, PhD, MPH (Medical University of South Carolina) · Sites: Charleston, South Carolina · Age: 1899 yrs
Other2 trials
Arabic PRO Measures for Head and Neck Cancer Radiotherapy.
Actively Recruiting
· Sites: Riyadh · Age: 1899 yrs
Microbiome in Head and Neck Squamous Cell Carcinoma
Actively Recruiting
PI: Shi-Long E Lu, MD, PhD (University of Colorado, Denver) · Sites: Aurora, Colorado · Age: 18100 yrs

Specialists

Showing 25 of 64View all specialists →
FM
Florence DUFFAUD, MD
Specialist
PI on 3 active trials
MM
Malcolm D Mattes
MORGANTOWN, WV
Specialist
PI on 1 active trial1 Squamous cell carcinoma of oral cavity and lip publication
HA
Hassan Arshad
CHICAGO, IL
Specialist
PI on 3 active trials3 Squamous cell carcinoma of oral cavity and lip publications
SL
Stephen Y Lai
Specialist
PI on 3 active trials56 Squamous cell carcinoma of oral cavity and lip publications
BL
Beverley de Valois, PhD LicAc
Specialist
PI on 1 active trial4 Squamous cell carcinoma of oral cavity and lip publications
RW
Randal S. Weber
HOUSTON, TX
Specialist
PI on 1 active trial
GY
George H. Yoo
DETROIT, MI
Specialist
PI on 1 active trial
JS
Jennifer L Shah
Specialist
PI on 1 active trial
KR
K. Thomas Robbins
Specialist
PI on 1 active trial
HS
Heath D Skinner
Specialist
PI on 1 active trial
PN
Phuc Felix Nguyen-Tan
Specialist
PI on 1 active trial
MK
Moni A. Kuriakose
BUFFALO, NY
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Squamous cell carcinoma of oral cavity and lip.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Squamous cell carcinoma of oral cavity and lipForum →

No community posts yet. Be the first to share your experience with Squamous cell carcinoma of oral cavity and lip.

Start the conversation →

Latest news about Squamous cell carcinoma of oral cavity and lip

Disease timeline:

New recruiting trial: Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial

A new clinical trial is recruiting patients for Squamous cell carcinoma of oral cavity and lip

New recruiting trial: Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of oral cavity and lip

New recruiting trial: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

A new clinical trial is recruiting patients for Squamous cell carcinoma of oral cavity and lip

New recruiting trial: Microbiome in Head and Neck Squamous Cell Carcinoma

A new clinical trial is recruiting patients for Squamous cell carcinoma of oral cavity and lip

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my cancer, and what does that mean for my treatment options?,Should my tumor be tested for HPV or other genetic changes, and how would that affect my treatment?,What are the likely side effects of the recommended treatment, and how long might they last?,Will I need reconstructive surgery, and what would recovery look like?,Are there clinical trials I might be eligible for?,What is the risk of the cancer coming back, and how will we monitor for that?,What support services are available to help with eating, speaking, and emotional wellbeing during treatment?

Common questions about Squamous cell carcinoma of oral cavity and lip

What is Squamous cell carcinoma of oral cavity and lip?

Squamous cell carcinoma of the oral cavity and lip (also called oral squamous cell carcinoma, or OSCC) is a type of cancer that starts in the flat, thin cells lining the inside of the mouth, lips, tongue, gums, cheeks, floor of the mouth, and the roof of the mouth. It is the most common type of mouth cancer. The cancer begins when these cells grow out of control and form a tumor. If not caught early, it can spread to nearby lymph nodes in the neck and, in more advanced cases, to other parts of the body. The most common warning signs include a sore in the mouth that does not heal, a white or r

How is Squamous cell carcinoma of oral cavity and lip inherited?

Squamous cell carcinoma of oral cavity and lip follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Squamous cell carcinoma of oral cavity and lip typically begin?

Typical onset of Squamous cell carcinoma of oral cavity and lip is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Squamous cell carcinoma of oral cavity and lip?

Yes — 18 recruiting clinical trials are currently listed for Squamous cell carcinoma of oral cavity and lip on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Squamous cell carcinoma of oral cavity and lip?

25 specialists and care centers treating Squamous cell carcinoma of oral cavity and lip are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.